Shares in BridgeBio were ticking up today after it revealed data from its phase 3 trial of infigratinib in achondroplasia, ...

Private equity firm expands healthcare focus. Inflexion, a leading European mid-market private equity firm, appointed John ...

EVERSANA, a leading provider of commercialisation services to the global life sciences industry, has named Monica Avram as ...

According to Invest Europe, the challenge facing the European life sciences sector is clear - Europe currently accounts for ...

Sanofi has announced a change of leadership, with former Merck KGaA chief executive Belén Garijo taking the helm of the ...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas. Built from ...

Zydus Lifesciences has reached a settlement agreement with Astellas in a patent dispute involving overactive bladder therapy Myrbetriq, which will allow its generic to remain on sale in the US.

PHARMAP 2026 addresses this transformation with a specialised session on patient-friendly design and its role in modern medicine. The event is scheduled for 20-21 April in Amsterdam. Trust and ...

In its main clinical trial, mRNA-1010 was shown to be 26.6% more effective than the comparator flu shot in adults aged 50 years and older. mRNA-based flu vaccines, which can be produced rapidly, have ...

Madrigal Pharma was the first drugmaker to bring a treatment for metabolic dysfunction-associated steatohepatitis (MASH) to ...

Streeting announced the plan to allow NHS England to put the processes in place to share primary care data with scientific ...

Novo Nordisk has been criticised by the FDA for a TV advertisement for its recently launched Wegovy pill, which the agency ...